Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹5.27 Cr₹-740 Cr₹605 Cr₹-7.81 Cr₹-527 Cr

What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Financing Activities ratio of MANKIND PHARMA is ₹5.27 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹5.27 Cr
Mar2023₹-740 Cr
Mar2022₹605 Cr
Mar2021₹-7.81 Cr
Mar2020₹-527 Cr

How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹5.27 Cr
Positive
Mar2023 ₹-740 Cr
Negative
Mar2022 ₹605 Cr
Positive
Mar2021 ₹-7.81 Cr
Negative
Mar2020 ₹-527 Cr -

Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,727.4 Cr -0.4% -7.8% 9.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,420.0 Cr -0.2% -2.9% 12.6% Stock Analytics
DIVIS LABORATORIES ₹177,572.0 Cr 0.3% 6.5% 49% Stock Analytics
CIPLA ₹123,329.0 Cr 1.1% 1.8% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,396.0 Cr -0.2% 9.5% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,956.0 Cr 1.9% 0.4% 14% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.4%

-7.8%

9.9%

SENSEX

-0.8%

-0.9%

6.9%


You may also like the below Video Courses